Long-term patient survival: strategies to improve overall health.
The use of potent immunosuppressant therapy has led to an increase in number of patients with successful long-term kidney transplants. These individuals come to kidney transplantation with varying levels of comorbidity associated with end-stage renal disease and are susceptible to immunologic and nonimmunologic comorbidities that arise late after transplantation, including cardiovascular disease, infection, malignancy, and bone disease, which negatively impact on patient and graft survival. In addition, nonadherence to immunosuppressant regimens increases with time after transplantation, which further augments the risk for late-term graft failure and mortality. Consistent and frequent follow-up of kidney transplant recipients beyond the first year permits early diagnosis and successful treatment of many posttransplantation comorbidities. Implementation of preventive practices and aggressive management of risk factors throughout the life of the transplant improves overall health and long-term outcomes. Establishment and maintenance of close relationships among transplant centers, physicians, patients, and their families improves patient adherence to medications and reduces the risk for morbidity and mortality.
Section on Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. padams@wfubmc.edu
Patricia L
PL
Adams
D002318:Cardiovascular Diseases / Q000517:prevention & control; D003266:Continuity of Patient Care; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications; D016030:Kidney Transplantation; D010349:Patient Compliance; D012307:Risk Factors; D014777:Virus Diseases / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy
D007166:Immunosuppressive Agents